Luis Caballero
CEO & CTO - Scientific Researcher at the Spanish National Research Council (CSIC)
HYBRIMS
Valencia, España
Medical devices based on imaging technologies for the precise diagnosis of cancer, facilitating personalized medicine to improve the patients clinical prognosis
Sobre
PhD in Physics and Senior Scientific Researcher at the Instituto de Física Corpuscular , joint centre between the Spanish Research Council (CSIC) and the University of Valencia, with more than 15 years of experience developing medical imaging equipment.
After my PhD I was hired at ONCOVISION (a spin-off company of the CSIC-UV) both as CTO and project manager to develop a portable gamma camera for intraoperative use and for the development of a PET system dedicated to breast).
I have a long track record in the development of gamma and neutron radiation measurement devices based on advanced nuclear physics instrumentation applied both in cutting-edge experiments in basic research on nuclear structure in international centres and laboratories (CERN, GANIL, etc.) and in its application to the fields of the nuclear industry, medical physics or the development of detectors for the study of space weather.
I currently lead projects at the Instituto de Fisica Corpuscular (CSIC-UV) developing devices for the detection of gamma rays for cancer biopsy, and for the optimization of the classification of radioactive waste generated in the dismantling tasks of nuclear power plants. He also leads the development of the LEON detector: an ultra-compact neutron detection system for the measurement of radiation in low orbits in nanosatellites (POLITECH-1 mission).
I am co-inventor of 5 patents in the field of medical imaging and gamma ray and neutron detection devices with extensive experience in the transfer of scientific results to companies. I have participated as a researcher in many regional, national and international collaboration projects.
Mi organización
HYBRID IMAGING SYSTEMS, S.L. (HYBRIMS) is a company dedicated to the design, development, manufacturing and marketing of medical devices based on imaging technologies for the precise diagnosis of cancer, facilitating personalized medicine to improve the clinical prognosis of the patient.
HYBRIMS is a Knowledge-Based Company (EBC or spin-off) of the Spanish National Research Council (CSIC) and the University of Valencia (UV) created from the development of a patented medical technology that combines gamma and ultrasound images with the capacity to guide cancer biopsies in real time. This novel device adds the metabolic information provided by gamma images, which display the most active or aggressive areas of the tumor, to the morphological information obtained with ultrasound, allowing the specialist to obtain more precise information about the tumor. The combination of both information ensures the biopsy of the most representative samples possible of the tumor and lymph nodes,
- allowing for personalized and precise oncological treatment
- improving the patient's diagnosis and prognosis
- reducing the overall costs of cancer treatment
- decreasing the patient's pain, stress and anxiety
Preguntas adicionales
Perfil
Empresa y/o startup¿Qué le gustaría encontrar en CV+i Health Day?